ALPHAMAB-B (09966.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec29

CanSino Biologics' JSKN033 clinical trial application accepted by CDE

04:19

Dec24

Simcere and partners' drug Ensituximab Granted Orphan Drug Designation by FDA

11:27

Dec22

Guojin Securities Gives BUY Rating to Konica Minolta Pharmaceutical-H

02:08

Dec18

KN003 Receives FDA Breakthrough Therapy Designation

04:09

Dec11

02:26

Nov26

Kangning Junrui Pharmaceutical-B Resolves to Repurchase Up to HKD 30 Million Ordinary Shares

06:15

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 174.82 M, Net Income 11.81 M, EPS 0.0109

Mar25

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 248.16 M, Net Income 112.36 M, EPS 0.1139

Aug15

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 93.25 M, Net Income -24.12 M, EPS -0.0268

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change